Studies have found that the combination of the PTPN11 inhibitor SHP099 and MEK inhibition can suppress the proliferation of various cancer cells including lung cancer; similarly, PTPN11 knockout and MEK inhibition have similar effects in vitro [28]. Here, PTPN11 is linked to lung cancer.